Register for email alerts and news feeds:
This journal | BMJ Group
rss
Published Online First: 9 January 2007. doi:10.1136/ard.2006.062984
Annals of the Rheumatic Diseases 2007;66:1173-1177
Copyright © 2007 BMJ Publishing Group Ltd & European League Against Rheumatism.

EXTENDED REPORT

Development of additional autoimmune diseases in a multiethnic cohort of patients with systemic lupus erythematosus with reference to damage and mortality

S A Chambers1, S C Charman2, A Rahman1, D A Isenberg1

1 The Centre for Rheumatology, Department of Medicine, University College London
2 Department of Statistical Sciences, University College London, Gower Street, London WC1E 6BT

Correspondence to:
Dr. Sharon Chambers
MRCP, The Centre for Rheumatology, University College London Hospital, 250 Euston Road, 3rd Floor Central, London NW1 2PG, UK; shrspk{at}aol.com

Objectives: To determine the prevalence of other autoimmune diseases (AID) in black, Caucasian and South Asian patients with systemic lupus erythematosus (SLE) compared with the prevalence of these AID in the UK population, and to assess the impact of these additional AID on damage scores and mortality.

Methods: The prevalence and chronology of development of additional AID in SLE patients was determined by case note review. Comparisons were made with prevalence data for AID in the general UK population. The impact of additional AID on mortality and damage scores at up to 10 years was determined in the index cases (patients who developed another AID either in the same year or within 5 years of onset of SLE) compared with controls matched for sex, age, ethnicity and year of onset of SLE.

Results: There was no significant difference in the total number of AID that developed in patients from each ethnic group but differences in the frequency of some AID were noted. Mortality and damage scores were worse at 5 years in the study cases than the controls, particularly in the peripheral vascular category.

Conclusion: Patients with SLE might develop other AID that could complicate management of SLE by having an adverse impact on damage scores and mortality.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • ICEN, M., NICOLA, P. J., MARADIT-KREMERS, H., CROWSON, C. S., THERNEAU, T. M., MATTESON, E. L., GABRIEL, S. E. (2009). Systemic Lupus Erythematosus Features in Rheumatoid Arthritis and Their Effect on Overall Mortality. The Journal of Rheumatology 36: 50-57 [Abstract] [Full Text]  

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

BMJ Careers - Latest Rheumatology Jobs

Rheumatology Jobs